Daclizumab (Zenapax) is a humanized monoclonal antibody designed to specifically target and block CD25, the ??-subunit of the high-affinity interleukin-2 receptor (IL-2R-HA). By reversibly binding to CD25, Daclizumab inhibits the interaction between interleukin-2 (IL-2) and its receptor, thereby modulating the immune response. This antibody is primarily utilized in research focused on multiple sclerosis, providing a valuable tool for investigating the pathophysiology and potential therapeutic interventions in this disease.
Daclizumab (Zenapax) is a humanized monoclonal antibody designed to specifically target and block CD25, the ??-subunit of the high-affinity interleukin-2 receptor (IL-2R-HA). By reversibly binding to CD25, Daclizumab inhibits the interaction between interleukin-2 (IL-2) and its receptor, thereby modulating the immune response. This antibody is primarily utilized in research focused on multiple sclerosis, providing a valuable tool for investigating the pathophysiology and potential therapeutic interventions in this disease.
This calculator helps you calculate mass of compound based on solution concentration, volume and molecular weight in a specific solution using the formula:
